It is a healthcare private limited company based in Mumbai, Maharashtra, India, established in 2017.
2017 | Mumbai, Maharashtra, India | ActiveNutech Cancer Biomarkers India Private Limited, a active private limited company, was established on 08 December 2017 in Mumbai, Maharashtra, India. Engaging in human health activities within the healthcare sector, it holds CIN: U85100MH2017PTC302616. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Tushar Kumar Kantilal Barad (Director), Kalpana Patel Kelavkar (Director), Uddhav Prabhakar Kelavkar (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No 4,Green Medows Complex, Akurli Road, Lokhandwala Circle, Kandivali East, Mumbai, Maharashtra, 400101.
U85100MH2017PTC302616
302616
08 December 2017
₹1.00 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Nutech Cancer Biomarkers India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tushar Kumar Kantilal Barad | Director | 08 Dec 2017 | Current |
| Kalpana Patel Kelavkar | Director | 08 Dec 2017 | Current |
| Uddhav Prabhakar Kelavkar | Director | 08 Dec 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nutech Cancer Biomarkers India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 33.43% increase in profit. The company's net worth observed a substantial decline by a decrease of 22.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Nutech Cancer Biomarkers India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Nutech Cancer Biomarkers India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nutech Cancer Biomarkers India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nutech Cancer Biomarkers India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nutech Cancer Biomarkers India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Nutech Cancer Biomarkers India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity Tushar Kumar Kantilal Barad was appointed as a Director was appointed as a Director on 08 Dec 2017 & has been associated with this company since 7 years 11 months . was completed.
Progress on Kalpana Patel Kelavkar was appointed as a Director was appointed as a Director on 08 Dec 2017 & has been associated with this company since 7 years 11 months . was documented.
Progress on Uddhav Prabhakar Kelavkar was appointed as a Director was appointed as a Director on 08 Dec 2017 & has been associated with this company since 7 years 11 months . was documented.
The activity Nutech Cancer Biomarkers India Private Limited was registered on 08 Dec 2017 with Roc Mumbai & aged 7 years 11 months as per MCA records. was completed.
The CIN of Nutech Cancer Biomarkers India Private Limited is U85100MH2017PTC302616.
Nutech Cancer Biomarkers India Private Limited is headquartered at Office No 4,Green Medows Complex, Akurli Road, Lokhandwala Circle, Kandivali East, Mumbai, Maharashtra, 400101.
Nutech Cancer Biomarkers India Private Limited was incorporated on 08 December 2017.
The current directors of Nutech Cancer Biomarkers India Private Limited are
The primary industry of Nutech Cancer Biomarkers India Private Limited is Healthcare.
Nutech Cancer Biomarkers India Private Limited is unlisted.
The authorized capital of Nutech Cancer Biomarkers India Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Nutech Cancer Biomarkers India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX